Midi Health

Midi Health operates a virtual healthcare clinic for women, initially focused on perimenopause and menopause and subsequently broadened to a wider range of midlife and general women's health needs. Patients book virtual visits without referrals, meet a clinician who reviews symptoms and health history, may have labs ordered, and receive a personalized "Care Plan" that can combine hormone prescriptions, non-hormone prescriptions, supplements and botanicals, lifestyle coaching and diagnostics such as metabolic panels, thyroid testing and insulin sensitivity markers. Follow-up visits are used to adjust treatment [0][2].

Beyond menopause symptoms such as hot flashes, night sweats, sleep problems, mood changes, brain fog, low libido, vaginal dryness, hair and skin changes, and joint pain, the company states it also addresses weight management, heart and metabolic health (cholesterol, blood pressure, pre-diabetes, blood clot risk), hormone and reproductive conditions (PCOS, fibroids, irregular periods, PMDD, contraception), mental health, urinary and vaginal infections, thyroid issues, and cancer survivorship and longevity care lines [2]. It sells supplements and some prescription products directly, in some cases after an asynchronous visit [2], and markets consumer products including GLP-1s, Daily Fiber+, Estriol+ Face Cream and Daily Cortisol Support [0].

As of the February 2026 Series D announcement, Midi described itself as a multispecialty platform with clinicians spanning OB-GYN, internal medicine, cardiology, endocrinology, survivorship, obesity, sleep, mood disorders, dermatology, longevity and naturopathic medicine, and said it planned to add care lines in metabolic health, weight management, musculoskeletal health and long-term wellness, with Medicare and Medicaid expansion on its roadmap [5][6].

Founding story

Midi Health was founded in 2021 by a female founding team to address the difficulty they had personally encountered in finding accessible, expert, insurance-covered treatment for perimenopause and menopause symptoms. The company started with a menopause focus and then broadened after concluding that women over 35 have extensive unmet health needs beyond fertility-related care [7].

Business model

Midi delivers virtual clinical care directly to patients and bills health insurance; it states it is in-network with most major health plans, with self-pay options available and no subscription fees. Coverage, deductibles, coinsurance and copays vary by plan [0][2]. The company also sells supplements and prescription products directly to consumers, some without a visit and some after an asynchronous or full clinician visit [2]. Historically it has also been offered through employers as a workplace benefit and through health system and benefits-platform partnerships [7].

Insurance reimbursement for virtual clinical visits, self-pay visits for patients without applicable coverage, and direct sales of supplements and prescription products [0][2].

Traction

Reported more than 230,000 patients and a clinician network of about 500 providers across 50 states, with roughly 25,000 patients seen each week and nationwide insurance coverage reaching more than 45 million women [6][5]. Company marketing cites 450,000+ women served, 95% of patients reporting peri/menopause symptom improvement after at least two months of care and 81% reporting less severe hot flashes and night sweats after 2+ months [0]. Reported outcomes include a 28 percentage point increase in breast cancer screening adherence, an 11 percentage point increase in colorectal cancer screening adherence, up to 13% lower total cost of care versus a matched comparison group, and reductions in A1c and LDL [5][6].

Latest developments

On 2026-02-03 Midi announced a $100 million Series D led by Goodwater Capital with new investors Foresite Capital and Serena Ventures and continued participation from Advance Venture Partners, GV, Emerson Collective, SemperVirens and McKesson Ventures, valuing the company above $1 billion. Alongside the round it named Jason Wheeler (previously Tesla, Google, Forward) CFO, Melissa Waters (previously Meta, Lyft, Hims & Hers) CMO, and Matt Cook (previously Omada Health, Firefly Health) CCO. Proceeds are earmarked for technology investment, clinician hiring, and new care lines in metabolic health, weight management, musculoskeletal health and long-term wellness, with Medicare and Medicaid expansion planned [5][6].